These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6262196)

  • 21. [Triphasic hormonal contraceptives].
    Vasilev D
    Akush Ginekol (Sofiia); 1989; 28(4):73-8. PubMed ID: 2679194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menstrual patterns under hormonal contraception in adolescent girls and young women.
    Heinz M
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():146-9. PubMed ID: 16641849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current status of and prospects for contraceptive methods].
    Vulkov I; Maleeva A
    Akush Ginekol (Sofiia); 1975; 14(3):224-31. PubMed ID: 769593
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cycle abnormalities and secondary sterility after estrogen-gestagen treatment].
    Gigon U; Zarro D; Stamm O
    Schweiz Z Gynakol Geburtshilfe; 1972; 3(2):133-40. PubMed ID: 12333145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gonadotropin and plasma cyclic nucleotides].
    Fujiwara T; Katayama K; Tojo S
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Nov; 34(11):1889-98. PubMed ID: 6294197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular composition of cervical smears in relation to the day of the menstrual cycle and the method of contraception.
    Vooijs GP; van der Graaf Y; Elias AG
    Acta Cytol; 1987; 31(4):417-26. PubMed ID: 3604536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hormonal tissue concentration and oral contraceptives: the endometrium].
    Carranco López A; Sojo Aranda I; Alonso Uriarte R; Castañeda Peña G; Bedolla Tovar N; Navarrete Arellano M; Cortés Gallegos V
    Ginecol Obstet Mex; 1979 Apr; 45(270):329-47. PubMed ID: 456926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of various oral contraceptive combinations on dysmenorrhea.
    Milsom I; Andersch B
    Gynecol Obstet Invest; 1984; 17(6):284-92. PubMed ID: 6745736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oral contraceptive agents and antithrombin III].
    Kamenov V; Nalbanski B
    Akush Ginekol (Sofiia); 1990; 29(1):60-3. PubMed ID: 1695492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral contraception.
    Helles AA
    Arch Pharm Chem (Kbh); 1971; 78():2-9. PubMed ID: 12334380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal factors and the laboratory detection of Chlamydia trachomatis in women: implications for screening?
    Crowley T; Horner P; Hughes A; Berry J; Paul I; Caul O
    Int J STD AIDS; 1997 Jan; 8(1):25-31. PubMed ID: 9043977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum prostaglandin F levels during menstrual cycle in women using oral contraceptives.
    Garg SK
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):431-2. PubMed ID: 6629547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gestagen-estrogen combinations in gynecology. On the history, dosage and use of a hormone principle].
    Kaiser R
    Geburtshilfe Frauenheilkd; 1993 Jul; 53(7):503-13. PubMed ID: 8370495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levels of protein S during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
    Jespersen J; Nielsen MT
    Gynecol Obstet Invest; 1989; 28(2):82-6. PubMed ID: 2529199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
    Prema K
    Contracept Deliv Syst; 1982 Jan; 3(1):39-46. PubMed ID: 12264126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigations of hormonal contraception in the young].
    Huber A
    Ther Ggw; 1976 Mar; 115(3):413-26. PubMed ID: 1265701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menstrual nirvana: amenorrhea through the use of continuous oral contraceptives.
    Edelman A
    Curr Womens Health Rep; 2002 Dec; 2(6):434-8. PubMed ID: 12429077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.
    Shulman LP
    Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased aldosterone plasma protein binding in women on combined oral contraceptives throughout the menstrual cycle.
    Nowaczynski W; Murakami T; Richardson K; Genest J
    J Clin Endocrinol Metab; 1978 Jul; 47(1):193-9. PubMed ID: 263655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The benefit of the classification of oral contraceptives. Studies of 525 women taking oral contraceptives (author's transl)].
    Wenderlein JM
    MMW Munch Med Wochenschr; 1981 Jun; 123(23):957-61. PubMed ID: 6789156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.